Pinchas Cohen is the dean of the USC Leonard Davis School of Gerontology, holds the William and Sylvia Kugel Dean's Chair in Gerontology and serves as the executive director of the Ethel Percy Andrus Gerontology Center. Cohen's research focuses on aging, neurodegeneration, cancer and diabetes with an emphasis on the emerging science of mitochondrial-derived peptides, which he discovered. He has also discussed the possibilities of applying personalized medicine to aging science, coining the term "personalized aging." His laboratory was one of three teams that independently discovered humanin (Cohen and his team had been screening for proteins that interact with IGFBP). Other mitochondrial peptides discovered by the Cohen laboratory include SHLP 1, 2, 3, 4, 5, and 6 and MOTS-C. He holds several patents for novel peptides and is the co-founder of CohBar, a biotechnology company developing peptides found in mitochondria for diabetes treatment. Cohen has published more than 250 papers in top scientific journals. An expert in the field, Cohen is president-elect of the Growth Hormone Society and served on the Endocrine Society Steering Committee. He sits on multiple NIH study sections and on several editorial boards.